Finally, the present study demonstrated that the AMPK signalling pathway regulates pluripotency factor expression (Sox2, Oct4 and Nanog) in ovarian cancer cells, suggesting that strategies targeting AMPK might provide a novel approach to control the cancer stem cells of EOC patients. Here, POU5F1 is linked to cancer.